Report
Linus Sigurdson
EUR 95.81 For Business Accounts Only

Kinnevik (Buy, TP: SEK110.00) - Have perk, will travel

Kinnevik’s Q4 marked an important return to NAV growth QOQ, driven mainly by the USD200m up round in TravelPerk (16% of assets), led by external investors EQT and Atomico. Continued operating progress in the core companies (set for >40% NTM revenue growth YOY), along with possible further up rounds, should help drive positive NAV revisions in 2025, while potential buybacks or signs of an IPO in e.g. Spring Health could drive a rerating of the still-high discount to NAV of 36%. We reiterate our BUY and have raised our target price to SEK110 (105), reflecting our new NAV estimate.
Underlying
KINNEVIK INVESTMENTS AB

Provider
DnB Markets
DnB Markets

DNB Markets is the investment banking arm of DNB Bank ASA and is focused primarily on the Nordic region, as well as internationally on niches such as global shipping, energy and related services, and seafood. DNB Markets offers services in FICC, Equities and Investment Banking advisory from offices in Oslo, Stockholm, London, Singapore and New York. Equity research coverage is offered on c250 Nordic companies. DNB was ranked no.2 in Extel Nordic Research 2017. The DNB Markets’ Credit and FICC Macro & FX Research teams are repeatedly highly rated by Prospera Nordic Institutional Investor Surveys.

 

Analysts
Linus Sigurdson

Other Reports on these Companies
Other Reports from DnB Markets

ResearchPool Subscriptions

Get the most out of your insights

Get in touch